• Robots, Technology, and A.I. — ‘Oh My!’
  • ALS Mutation Kills Nerve Cells by Preventing Protein Clumps from Breaking Apart, Study Reports
  • Perceptive Devices and Tobii Dynavox Partnership Will Combine Facial Expression and Eye Tracking Technology
  • ALS Association Celebrates 3rd Anniversary of ALS Ice Bucket Challenge with New Campaign
  • Increasing Dok-7 Protein Levels May Improve ALS Patients’ Muscle Function, Study Reports
  • Radicava Hopes, Expectations from NFL’s William White and Doctors at Ohio State
  • Gene Editing System Revamped to Target RNA Aggregates Found in Inherited ALS
  • Too Many Names, Too Little Time
  • Radicava, First Approved Therapy for ALS Since 1995, Now Available for U.S. Patients
  • Brazilian Doctors Prescribing Hemp Cannabis Products to ALS and Psoriasis Patients
  • BrainStorm Appoints VP of Patient Advocacy and Government Affairs
  • Amylyx Pharmaceuticals Doses First Patient in Phase 2 Trial of AMX0035 as an ALS Therapy